Home
Flashcards
Preview
Endocrine: Gestational DM
Home
Get App
Take Quiz
Create
Prolactin and human placental lactogen (hPL)
elevated
Serotonin production in beta-cells increased
beta-cell expansion
beta-cell glucose sensitivity increases
Insulin secretory capacity increases
No changes in alpha-cell mass or glucagon
secretion
Inc Progesterone
-> increased insulin resistance
Glucose Gradient
Decreases as gestation progresses
-> increased insulin resistance
Risks assoc. w/GDM
Pre-eclampsia
Birthing large for gestational age (LGA) babies
Macrosomia
LGA birth
GDM Dx (1 Step)
Fasting 100g OGTT
GDM Dx (2Step)
Fasting 50g oral glucose challenge test
if >/= 130-140 -> Fasting 100g OGTT
Ethnic High Risk Groups
AA
Asian
Hispanic
NA
PI
Low Risk Criteria
Low risk ethnic group
< 25 yo
No 1st
o
relative w/DM
Pre-pregnancy BMI < 25
Normal birth weight
No Hx of poor obstetric outcomes
No Hx of poor glucose metabolism
(No test)
High Risk Criteria
Severely obese
FH of T2DM
Hx of GDM
(test STAT)
Average Risk
(test @ 24-28 weeks)
GDM Tx
Insulin
Glyburide (stop 2wks pre-delivery)
Metformin
DM Tx during delivery
NPH QHS
AM dose held -> normal saline infusion
change to D5W @ <70 or active labor
1.25 U/h @ >100 (adj. PRN)
Hourly finger sticks
Infant Hyperinsulinemia
Occurs @ birth d/t 2nd/3rd trimester poor glucose control
Hypokalemia
Hypocalcemia
Hypomagnesemia
Hypoglycemia (<25-40 mg/dL)
Infant Polycythemia
Inc. O2 demand d/t inc. catabolism
Increased red cell production
Hyperbilirubinemia (Inc. red cell turnover)
IDM (infant of diabetic mother) Tx
D10W 1-2 mL/kg
Author
jcbarbery
ID
214862
Card Set
Endocrine: Gestational DM
Description
Overview of gestational diabetes and its treatment.
Updated
2013-04-21T19:33:43Z
Show Answers
Home
Flashcards
Preview